US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 4.195
  • +0.185+4.61%
Trading Jul 23 11:25 ET
438.16MMarket Cap-1143P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
13.46%51.94M
76.55%234.04M
39.82%69.8M
95.68%56.78M
104.93%58.13M
81.20%45.77M
70.40%132.57M
92.37%49.92M
46.95%29.02M
50.86%28.37M
Operating revenue
13.46%51.94M
76.55%234.04M
39.82%69.8M
95.68%56.78M
104.93%58.13M
81.20%45.77M
70.40%132.57M
92.37%49.92M
46.95%29.02M
50.86%28.37M
Cost of revenue
19.41%14.91M
43.93%74.36M
-25.70%17.47M
80.82%19.41M
123.74%21.31M
58.20%12.49M
120.70%51.67M
198.38%23.52M
82.40%10.74M
75.51%9.52M
Gross profit
11.23%37.03M
97.38%159.68M
98.16%52.33M
104.40%37.36M
95.42%36.83M
91.66%33.29M
48.74%80.9M
46.14%26.41M
31.89%18.28M
40.87%18.85M
Operating expense
4.82%83.85M
8.20%382.01M
4.68%105.75M
-13.60%82.74M
33.43%102.33M
0.51%80M
7.29%353.07M
26.80%101.03M
10.60%95.76M
-8.40%76.69M
Selling and administrative expenses
11.30%68.91M
33.02%292.24M
31.32%84.3M
4.62%67.73M
63.03%76.34M
40.92%61.92M
10.50%219.7M
30.20%64.19M
25.05%64.74M
-5.74%46.83M
-Selling and marketing expense
----
38.41%253.42M
----
----
----
----
--183.1M
----
----
----
-General and administrative expense
----
6.06%38.81M
-42.23%-169.13M
4.62%67.73M
63.03%76.34M
----
--36.6M
---118.91M
25.05%64.74M
-5.74%46.83M
Research and development costs
-17.90%14.39M
-21.60%79.41M
4.22%20.37M
-49.97%13.06M
-8.45%22.81M
-42.95%17.53M
-12.88%101.29M
-33.69%19.54M
-13.26%26.1M
-15.38%24.91M
Depreciation amortization depletion
0.00%545K
-67.70%10.36M
-93.70%1.09M
-60.33%1.95M
-35.79%3.18M
-88.92%545K
129.38%32.09M
1,809.27%17.3M
4.37%4.92M
7.62%4.95M
-Depreciation and amortization
0.00%545K
-67.70%10.36M
-93.70%1.09M
-60.33%1.95M
-35.79%3.18M
-88.92%545K
129.38%32.09M
1,809.27%17.3M
4.37%4.92M
7.62%4.95M
Operating profit
-0.25%-46.83M
18.31%-222.34M
28.41%-53.43M
41.43%-45.38M
-13.24%-65.5M
24.93%-46.71M
0.91%-272.17M
-21.13%-74.62M
-6.55%-77.48M
17.76%-57.84M
Net non-operating interest income expense
-48.00%-2.26M
47.59%-6.07M
-172.40%-1.96M
76.36%-1.36M
62.52%-1.22M
17.68%-1.53M
-95.13%-11.58M
52.00%-721K
-286.82%-5.75M
-119.34%-3.26M
Non-operating interest income
0.88%3M
171.62%13.29M
13.30%3.43M
220.43%3.73M
408.56%3.15M
3,807.89%2.97M
1,351.34%4.89M
4,169.01%3.03M
1,286.90%1.17M
628.24%619K
Non-operating interest expense
16.88%5.26M
17.49%19.36M
43.87%5.4M
-26.37%5.09M
12.75%4.37M
132.88%4.5M
162.62%16.47M
138.53%3.75M
340.29%6.92M
146.91%3.87M
Other net income (expense)
-87.18%-438K
-32.39%-95.28M
99.56%-310K
-12,335.54%-94.14M
-77.22%-599K
12.03%-234K
-10,210.89%-71.97M
-882,712.50%-70.61M
-356.02%-757K
10.11%-338K
Special income (charges)
----
-35.33%-94.44M
99.24%-528K
---93.91M
----
----
---69.79M
---69.79M
--0
----
-Less：Restructuring and merger&acquisition
----
--1.26M
--528K
--732K
----
----
--0
--0
--0
----
-Less:Impairment of capital assets
----
33.52%93.18M
--0
--93.18M
----
----
--69.79M
--69.79M
--0
----
Other non- operating income (expenses)
-87.18%-438K
61.58%-838K
126.59%218K
70.54%-223K
-77.22%-599K
12.03%-234K
-212.46%-2.18M
-811.11%-820K
-418.49%-757K
5.32%-338K
Income before tax
-2.17%-49.53M
9.01%-323.69M
61.84%-55.7M
-67.72%-140.88M
-9.58%-67.32M
24.67%-48.47M
-26.45%-355.72M
-131.31%-145.95M
-12.93%-83.99M
14.91%-61.44M
Income tax
-57.14%300K
0
-57.14%300K
-119.57%-64K
700K
0
700K
327K
Net income
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-8.89%-67.25M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
-13.87%-84.69M
14.45%-61.76M
Net income continuous Operations
-2.17%-49.53M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-8.89%-67.25M
24.67%-48.47M
-26.70%-356.42M
-131.31%-145.95M
-13.87%-84.69M
14.45%-61.76M
Net income discontinuous operations
67.97%-3.63M
----
----
----
----
---11.32M
----
----
----
----
Minority interest income
Net income attributable to the parent company
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-8.89%-67.25M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
-13.87%-84.69M
14.45%-61.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-8.89%-67.25M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
-13.87%-84.69M
14.45%-61.76M
Basic earnings per share
21.62%-0.58
21.84%-3.83
65.38%-0.63
-39.32%-1.63
9.09%-0.8
21.28%-0.74
-17.51%-4.9
-95.70%-1.82
-6.36%-1.17
17.76%-0.88
Diluted earnings per share
21.62%-0.58
21.84%-3.83
65.38%-0.63
-39.32%-1.63
9.09%-0.8
21.28%-0.74
-17.51%-4.9
-95.70%-1.82
-6.36%-1.17
17.76%-0.88
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 13.46%51.94M76.55%234.04M39.82%69.8M95.68%56.78M104.93%58.13M81.20%45.77M70.40%132.57M92.37%49.92M46.95%29.02M50.86%28.37M
Operating revenue 13.46%51.94M76.55%234.04M39.82%69.8M95.68%56.78M104.93%58.13M81.20%45.77M70.40%132.57M92.37%49.92M46.95%29.02M50.86%28.37M
Cost of revenue 19.41%14.91M43.93%74.36M-25.70%17.47M80.82%19.41M123.74%21.31M58.20%12.49M120.70%51.67M198.38%23.52M82.40%10.74M75.51%9.52M
Gross profit 11.23%37.03M97.38%159.68M98.16%52.33M104.40%37.36M95.42%36.83M91.66%33.29M48.74%80.9M46.14%26.41M31.89%18.28M40.87%18.85M
Operating expense 4.82%83.85M8.20%382.01M4.68%105.75M-13.60%82.74M33.43%102.33M0.51%80M7.29%353.07M26.80%101.03M10.60%95.76M-8.40%76.69M
Selling and administrative expenses 11.30%68.91M33.02%292.24M31.32%84.3M4.62%67.73M63.03%76.34M40.92%61.92M10.50%219.7M30.20%64.19M25.05%64.74M-5.74%46.83M
-Selling and marketing expense ----38.41%253.42M------------------183.1M------------
-General and administrative expense ----6.06%38.81M-42.23%-169.13M4.62%67.73M63.03%76.34M------36.6M---118.91M25.05%64.74M-5.74%46.83M
Research and development costs -17.90%14.39M-21.60%79.41M4.22%20.37M-49.97%13.06M-8.45%22.81M-42.95%17.53M-12.88%101.29M-33.69%19.54M-13.26%26.1M-15.38%24.91M
Depreciation amortization depletion 0.00%545K-67.70%10.36M-93.70%1.09M-60.33%1.95M-35.79%3.18M-88.92%545K129.38%32.09M1,809.27%17.3M4.37%4.92M7.62%4.95M
-Depreciation and amortization 0.00%545K-67.70%10.36M-93.70%1.09M-60.33%1.95M-35.79%3.18M-88.92%545K129.38%32.09M1,809.27%17.3M4.37%4.92M7.62%4.95M
Operating profit -0.25%-46.83M18.31%-222.34M28.41%-53.43M41.43%-45.38M-13.24%-65.5M24.93%-46.71M0.91%-272.17M-21.13%-74.62M-6.55%-77.48M17.76%-57.84M
Net non-operating interest income expense -48.00%-2.26M47.59%-6.07M-172.40%-1.96M76.36%-1.36M62.52%-1.22M17.68%-1.53M-95.13%-11.58M52.00%-721K-286.82%-5.75M-119.34%-3.26M
Non-operating interest income 0.88%3M171.62%13.29M13.30%3.43M220.43%3.73M408.56%3.15M3,807.89%2.97M1,351.34%4.89M4,169.01%3.03M1,286.90%1.17M628.24%619K
Non-operating interest expense 16.88%5.26M17.49%19.36M43.87%5.4M-26.37%5.09M12.75%4.37M132.88%4.5M162.62%16.47M138.53%3.75M340.29%6.92M146.91%3.87M
Other net income (expense) -87.18%-438K-32.39%-95.28M99.56%-310K-12,335.54%-94.14M-77.22%-599K12.03%-234K-10,210.89%-71.97M-882,712.50%-70.61M-356.02%-757K10.11%-338K
Special income (charges) -----35.33%-94.44M99.24%-528K---93.91M-----------69.79M---69.79M--0----
-Less：Restructuring and merger&acquisition ------1.26M--528K--732K----------0--0--0----
-Less:Impairment of capital assets ----33.52%93.18M--0--93.18M----------69.79M--69.79M--0----
Other non- operating income (expenses) -87.18%-438K61.58%-838K126.59%218K70.54%-223K-77.22%-599K12.03%-234K-212.46%-2.18M-811.11%-820K-418.49%-757K5.32%-338K
Income before tax -2.17%-49.53M9.01%-323.69M61.84%-55.7M-67.72%-140.88M-9.58%-67.32M24.67%-48.47M-26.45%-355.72M-131.31%-145.95M-12.93%-83.99M14.91%-61.44M
Income tax -57.14%300K0-57.14%300K-119.57%-64K700K0700K327K
Net income 11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-8.89%-67.25M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M-13.87%-84.69M14.45%-61.76M
Net income continuous Operations -2.17%-49.53M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-8.89%-67.25M24.67%-48.47M-26.70%-356.42M-131.31%-145.95M-13.87%-84.69M14.45%-61.76M
Net income discontinuous operations 67.97%-3.63M-------------------11.32M----------------
Minority interest income
Net income attributable to the parent company 11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-8.89%-67.25M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M-13.87%-84.69M14.45%-61.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-8.89%-67.25M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M-13.87%-84.69M14.45%-61.76M
Basic earnings per share 21.62%-0.5821.84%-3.8365.38%-0.63-39.32%-1.639.09%-0.821.28%-0.74-17.51%-4.9-95.70%-1.82-6.36%-1.1717.76%-0.88
Diluted earnings per share 21.62%-0.5821.84%-3.8365.38%-0.63-39.32%-1.639.09%-0.821.28%-0.74-17.51%-4.9-95.70%-1.82-6.36%-1.1717.76%-0.88
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.52%